TY - JOUR AU - Harms, K. L. AU - Healy, M. A. AU - Nghiem, P. PY - 2016 DA - 2016// TI - Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system JO - Ann Surg Oncol VL - 23 UR - https://doi.org/10.1245/s10434-016-5266-4 DO - 10.1245/s10434-016-5266-4 ID - Harms2016 ER - TY - JOUR AU - Schadendorf, D. AU - Lebbé, C. AU - Zur Hausen, A. PY - 2016 DA - 2016// TI - Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs JO - Eur J Cancer VL - 71 UR - https://doi.org/10.1016/j.ejca.2016.10.022 DO - 10.1016/j.ejca.2016.10.022 ID - Schadendorf2016 ER - TY - JOUR AU - Heath, M. AU - Jaimes, N. AU - Lemos, B. PY - 2008 DA - 2008// TI - Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the “AEIOU” features JO - J Am Acad Dermatol VL - 58 UR - https://doi.org/10.1016/j.jaad.2007.11.020 DO - 10.1016/j.jaad.2007.11.020 ID - Heath2008 ER - TY - JOUR AU - Feng, H. AU - Shuda, M. AU - Chang, Y. PY - 2008 DA - 2008// TI - Clonal integration of a polyomavirus in human Merkel cell carcinoma JO - Science VL - 319 UR - https://doi.org/10.1126/science.1152586 DO - 10.1126/science.1152586 ID - Feng2008 ER - TY - JOUR AU - Afanasiev, O. K. AU - Yelistratova, L. AU - Miller, N. PY - 2013 DA - 2013// TI - Merkel polyomavirus-specific T cells fluctuate with Merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-0035 DO - 10.1158/1078-0432.CCR-13-0035 ID - Afanasiev2013 ER - TY - JOUR AU - Merritt, H. AU - Sniegowski, M. C. AU - Esmaeli, B. PY - 2014 DA - 2014// TI - Merkel cell carcinoma of the eyelid and periocular region JO - Cancers VL - 6 UR - https://doi.org/10.3390/cancers6021128 DO - 10.3390/cancers6021128 ID - Merritt2014 ER - TY - JOUR AU - Rubsamen, P. E. AU - Tanenbaum, M. AU - Grove, A. S. PY - 1992 DA - 1992// TI - Merkel cell carcinoma of the eyelid and periocular tissues JO - Am J Ophthalmol VL - 113 UR - https://doi.org/10.1016/S0002-9394(14)74793-2 DO - 10.1016/S0002-9394(14)74793-2 ID - Rubsamen1992 ER - TY - JOUR AU - Pectasides, D. AU - Pectasides, M. AU - Psyrri, A. PY - 2006 DA - 2006// TI - Cisplatin-based chemotherapy for Merkel cell carcinoma of the skin JO - Cancer Investig VL - 24 UR - https://doi.org/10.1080/07357900601062354 DO - 10.1080/07357900601062354 ID - Pectasides2006 ER - TY - BOOK PY - 2018 DA - 2018// TI - NCCN clinical practice guidelines in oncology. Version 1 ID - ref9 ER - TY - JOUR AU - Tai, P. T. AU - Yu, E. AU - Winquist, E. PY - 2000 DA - 2000// TI - Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.12.2493 DO - 10.1200/JCO.2000.18.12.2493 ID - Tai2000 ER - TY - JOUR AU - Kaufman, H. L. AU - Russell, J. AU - Hamid, O. PY - 2016 DA - 2016// TI - Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30364-3 DO - 10.1016/S1470-2045(16)30364-3 ID - Kaufman2016 ER - TY - JOUR AU - Kaufman, H. L. AU - Russell, J. AU - Hamid, O. PY - 2018 DA - 2018// TI - Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-017-0310-x DO - 10.1186/s40425-017-0310-x ID - Kaufman2018 ER - TY - JOUR AU - Nghiem, P. T. AU - Bhatia, S. AU - Lipson, E. J. PY - 2016 DA - 2016// TI - PD-1 blockade with Pembrolizumab in advanced Merkel-cell carcinoma JO - New Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1603702 DO - 10.1056/NEJMoa1603702 ID - Nghiem2016 ER - TY - JOUR AU - Walocko, F. M. AU - Scheier, B. Y. AU - Harms, P. W. PY - 2016 DA - 2016// TI - Metastatic Merkel cell carcinoma response to nivolumab JO - J Immunother Cancer VL - 4 UR - https://doi.org/10.1186/s40425-016-0186-1 DO - 10.1186/s40425-016-0186-1 ID - Walocko2016 ER - TY - JOUR AU - Topalian, S. L. AU - Bhatia, S. AU - Hollebecque, A. PY - 2017 DA - 2017// TI - Abstract CT074: non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): efficacy and safety in Merkel cell carcinoma (MCC) JO - Am Assoc Cancer Res VL - 77 UR - https://doi.org/10.1158/1538-7445.AM2017-CT074 DO - 10.1158/1538-7445.AM2017-CT074 ID - Topalian2017 ER - TY - JOUR AU - Topalian, S. u. z. a. n. n. e. L. o. u. i. s. e. AU - Bhatia, S. h. a. i. l. e. n. d. e. r. AU - Kudchadkar, R. a. g. i. n. i. R. e. i. n. e. y. AU - Amin, A. s. i. m. AU - Sharfman, W. i. l. l. i. a. m. H. o. w. a. r. d. AU - Lebbe, C. e. l. e. s. t. e. AU - Delord, J. e. a. n. -. P. i. e. r. r. e. AU - Shinohara, M. i. c. h. i. M. AU - Baxi, S. h. r. u. j. a. l. S. AU - Chung, C. h. r. i. s. t. i. n. e. H. AU - Martens, U. w. e. M. a. r. c. AU - Ferris, R. o. b. e. r. t. L. AU - Stein, J. u. l. i. e. E. AU - Soumaoro, I. b. r. a. h. i. m. a. AU - Zwirtes, R. i. c. a. r. d. o. F. AU - Chen, T. i. a. n. AU - Cao, Z. A. l. e. x. a. n. d. e. r. AU - Taube, J. a. n. i. s. M. AU - Nghiem, P. a. u. l. PY - 2018 DA - 2018// TI - Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358 JO - Journal of Clinical Oncology VL - 36 UR - https://doi.org/10.1200/JCO.2018.36.15_suppl.9505 DO - 10.1200/JCO.2018.36.15_suppl.9505 ID - Topalian2018 ER - TY - JOUR AU - Howard, R. A. AU - Dores, G. M. AU - Curtis, R. E. PY - 2006 DA - 2006// TI - Merkel cell carcinoma and multiple primary cancers JO - Cancer Epidemiol Biomark Prev VL - 15 UR - https://doi.org/10.1158/1055-9965.EPI-05-0895 DO - 10.1158/1055-9965.EPI-05-0895 ID - Howard2006 ER - TY - JOUR AU - Borghaei, H. AU - Paz-Ares, L. AU - Horn, L. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1507643 DO - 10.1056/NEJMoa1507643 ID - Borghaei2015 ER - TY - JOUR AU - Wong, S. Q. AU - Waldeck, K. AU - Vergara, I. A. AU - Schröder, J. AU - Madore, J. AU - Wilmott, J. S. PY - 2015 DA - 2015// TI - UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-15-1877 DO - 10.1158/0008-5472.CAN-15-1877 ID - Wong2015 ER - TY - JOUR AU - Paulson, K. G. AU - Iyer, J. G. AU - Blom, A. PY - 2013 DA - 2013// TI - Systemic immune suppression as a stage-independent predictor of diminished Merkel cell carcinoma-specific survival JO - J Invest Dermatol VL - 133 UR - https://doi.org/10.1038/jid.2012.388 DO - 10.1038/jid.2012.388 ID - Paulson2013 ER - TY - JOUR AU - Brewer, J. D. AU - Shanafelt, T. D. AU - Otley, C. C. PY - 2012 DA - 2012// TI - Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.34.9605 DO - 10.1200/JCO.2011.34.9605 ID - Brewer2012 ER - TY - JOUR AU - Quaglino, D. AU - Di Leonardo, G. AU - Lalli, G. PY - 1997 DA - 1997// TI - Association between chronic lymphocytic leukaemia and secondary tumours: unusual occurrence of a neuroendocrine (Merkel cell) carcinoma JO - Eur Rev Med Pharmacol Sci VL - 1 ID - Quaglino1997 ER - TY - JOUR AU - Engels, E. A. AU - Frisch, M. AU - Goedert, J. J. PY - 2002 DA - 2002// TI - Merkel cell carcinoma and HIV infection JO - Lancet VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)07668-7 DO - 10.1016/S0140-6736(02)07668-7 ID - Engels2002 ER - TY - JOUR AU - Penn, I. AU - First, M. R. PY - 1999 DA - 1999// TI - Merkel's cell carcinoma in organ recipients: report of 41 cases JO - Transplantation VL - 68 UR - https://doi.org/10.1097/00007890-199912150-00015 DO - 10.1097/00007890-199912150-00015 ID - Penn1999 ER - TY - JOUR AU - Hemminki, K. AU - Liu, X. AU - Ji, J. PY - 2012 DA - 2012// TI - Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.27376 DO - 10.1002/ijc.27376 ID - Hemminki2012 ER - TY - JOUR AU - Viscidi, R. P. AU - Rollison, D. E. AU - Sondak, V. K. PY - 2011 DA - 2011// TI - Age-specific Seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus JO - Clin Vaccine Immunol VL - 18 UR - https://doi.org/10.1128/CVI.05175-11 DO - 10.1128/CVI.05175-11 ID - Viscidi2011 ER - TY - JOUR AU - Lasithiotaki, I. AU - Antoniou, K. M. AU - Derdas, S. P. PY - 2013 DA - 2013// TI - The presence of Merkel cell polyomavirus is associated with deregulated expression of BRAF and Bcl-2 genes in non-small cell lung cancer JO - Int J Cancer VL - 133 UR - https://doi.org/10.1002/ijc.28062 DO - 10.1002/ijc.28062 ID - Lasithiotaki2013 ER - TY - JOUR AU - Hashida, Y. u. m. i. k. o. AU - Daibata, M. a. s. a. n. o. r. i. PY - 2014 DA - 2014// TI - Considerations on the link between Merkel cell polyomavirus and lung cancer JO - Lung Cancer Management VL - 3 UR - https://doi.org/10.2217/lmt.14.20 DO - 10.2217/lmt.14.20 ID - Hashida2014 ER - TY - JOUR AU - Kim, G. J. AU - Lee, J. -. H. AU - Lee, D. H. PY - 2017 DA - 2017// TI - Clinical and prognostic significance of Merkel cell polyomavirus in non small cell lung cancer JO - Medicine VL - 96 UR - https://doi.org/10.1097/MD.0000000000005413 DO - 10.1097/MD.0000000000005413 ID - Kim2017 ER - TY - JOUR AU - Coggshall, K. AU - Tello, T. L. AU - North, J. P. PY - 2018 DA - 2018// TI - Merkel cell carcinoma: an update and review: pathogenesis, diagnosis, and staging JO - J Am Acad Dermatol VL - 78 UR - https://doi.org/10.1016/j.jaad.2017.12.001 DO - 10.1016/j.jaad.2017.12.001 ID - Coggshall2018 ER - TY - JOUR AU - Edwards, I. R. AU - Aronson, J. K. PY - 2000 DA - 2000// TI - Adverse drug reactions: definitions, diagnosis, and management JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02799-9 DO - 10.1016/S0140-6736(00)02799-9 ID - Edwards2000 ER -